• Science & Technology

Personalised blood test could help predict which lung cancers might return

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test. Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

1 April 2022

• Health & Medicine

Is there a right way to check your body for cancer? 

There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking. There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking.

29 March 2022

• Science & Technology

Paving the way: How biopsies are offering hope to children with aggressive brain tumours

7 March 2022

• Science & Technology

Advanced MRI could help to differentiate aggressive and slower growing prostate cancer

New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways. New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways.

14 February 2022

• Science & Technology
• Health & Medicine

Targeted prostate cancer screening: Are we there yet?

Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet? Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet?

20 October 2021

• For Researchers

Prize winning early detection research

Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers... Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers...

7 October 2021

• Science & Technology

The Galleri multi-cancer blood test: What you need to know

There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test. There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test.

13 September 2021

• For Researchers

Speaking a thousand words – how a cancer image collection is set to improve AI diagnosis

Find out how the OPTIMAM project’s mammogram collection is heralding a new dawn of machine learning based cancer detection Find out how the OPTIMAM project’s mammogram collection is heralding a new dawn of machine learning based cancer detection

8 September 2021

• Science & Technology

Scientists developing urine and blood tests to detect brain tumours

Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma. Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.

23 July 2021

• Health & Medicine

Blood test could tailor treatment after surgery

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible. A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.

14 July 2021

• Science & Technology

Urine test for bladder cancer being developed

The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures. The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures.

2 July 2021

• Science & Technology
• Health & Medicine

Cytosponge-AI combo could help doctors diagnose Barrett’s oesophagus

Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer. Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer.

15 April 2021